Insider Trading Activity Intersect ENT, Inc. (NASDAQ:XENT) – COO Sold 12,500 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Intersect ENT, Inc. (NASDAQ:XENT)

Richard E Kaufman , COO of Intersect ENT, Inc. (NASDAQ:XENT) reportedly Sold 12,500 shares of the company’s stock at an average price of 28.25 for a total transaction amount of $353,125.00 SEC Form

Insider Trading History For Intersect ENT, Inc. (NASDAQ:XENT)

On 9/11/2014 Cynthia L Lucchese, Director, bought 5,000 with an average share price of $17.11 per share and the total transaction amounting to $85,550.00.View SEC Filing

On 1/26/2015 Robert H Binney Jr, VP, sold 6,300 with an average share price of $21.18 per share and the total transaction amounting to $133,434.00.View SEC Filing

On 2/2/2015 James Stambaugh, VP, sold 8,343 with an average share price of $20.98 per share and the total transaction amounting to $175,036.14.View SEC Filing

On 2/12/2015 Amy Wolbeck, VP, sold 8,000 with an average share price of $22.12 per share and the total transaction amounting to $176,960.00.View SEC Filing

On 2/17/2015 Lisa D Earnhardt, Insider, sold 19,318 with an average share price of $22.69 per share and the total transaction amounting to $438,325.42.View SEC Filing

On 3/9/2015 James Stambaugh, VP, sold 8,343 with an average share price of $23.02 per share and the total transaction amounting to $192,055.86.View SEC Filing

On 3/11/2015 Amy Wolbeck, VP, sold 8,000 with an average share price of $23.06 per share and the total transaction amounting to $184,480.00.View SEC Filing

Analyst Ratings For Intersect ENT, Inc. (NASDAQ:XENT)
These are 3 Hold Ratings, 7 Buy Ratings .
The current consensus rating for Intersect ENT, Inc. (NASDAQ:XENT) is Buy (Score: 2.70) with a consensus target price of $18.78 , a potential (33.41% downside)

Analyst Ratings History For Intersect ENT, Inc. (NASDAQ:XENT)

On 10/2/2015 Sterne Agee CRT Reiterated Rating Buy with a price target of $37.00
On 12/18/2015 Bank of America Corporation Initiated Coverage of rating Buy with a price target of $26.00
On 3/24/2016 Cantor Fitzgerald Reiterated Rating Buy with a price target of $29.00
On 8/4/2016 BTIG Research Reiterated Rating Hold with a price target of $14.00
On 8/26/2016 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $21.00
On 11/2/2016 J P Morgan Chase & Co Downgraded rating Overweight to Neutral with a price target of $25.00 to $16.00
On 11/4/2016 Leerink Swann Reiterated Rating Outperform with a price target of $21.00 to $14.00

Recent Trading Activity for Intersect ENT, Inc. (NASDAQ:XENT)
Shares of Intersect ENT, Inc. closed the previous trading session at 28.20 down -0.25 -0.88% with 301,483 shares trading hands.